Cargando…
Treatment outcomes of long-acting injectable naltrexone versus oral naltrexone in alcohol use disorder in veterans
INTRODUCTION: In veterans, the prevalence of 12-month and lifetime alcohol use disorder (AUD) is 14.8% and 42.2%, respectively. Alcohol use disorder treatment is often plagued by medication discontinuation with relapse rates being as high as 39% in patients who sought treatment. One proposed benefit...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
College of Psychiatric & Neurologic Pharmacists
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881114/ https://www.ncbi.nlm.nih.gov/pubmed/31857935 http://dx.doi.org/10.9740/mhc.2019.11.392 |